Oral discomfort and health behavior of patients with typical vs. atypical antipsychotic drugs

被引:1
作者
Meurman, Jukka H. [1 ,2 ]
Murtomaa, Heikki [1 ]
机构
[1] Univ Helsinki, Dept Oral & Maxillofacial Dis, Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Dept Oral & Maxillofacial Dis, Helsinki, Finland
来源
FRONTIERS IN PSYCHIATRY | 2024年 / 15卷
关键词
mental health; mental disorders; antipsychotic drugs; burning mouth; oral pain; xerostomia; health behavior; BURNING MOUTH SYNDROME; QUALITY-OF-LIFE; NEUROLEPTICS; INPATIENTS;
D O I
10.3389/fpsyt.2024.1420010
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Introduction: Psychiatric patients suffer from oral diseases and side effects of antipsychotic medication. In particular, the typical antipsychotic drugs may cause severe hyposalivation with subsequent oral symptoms. We therefore aimed to compare oral health behavior and oral side effects of in-hospital patients taking typical vs. atypical antipsychotic drugs with the hypothesis that the former drugs cause more oral pain than the newer drugs. Methods: This cross-sectional questionnaire and interview study investigated subjective oral symptoms and their health behavior in 170 hospitalized psychiatric patients, comparing those taking typical vs. atypical antipsychotic drugs. Cross-tabulations and chi-square tests were used for analyses. Results: Persistent oral pain lasting throughout the day was reported by 46% in the typical, and 5% in the atypical antipsychotic group patients, respectively. In both groups, the pain was mainly in the tongue and buccal mucosa and was described as a burning sensation. A significantly higher prevalence of xerostomia was reported in the typical antipsychotic medication group (66%) compared with the atypical antipsychotic medication group (53%, p<0.01). Self-assessed dental health was assessed as poor by two-thirds of the patients of whom 69% reported toothbrushing once daily. Approximately half of them reported having had a visit to a dentist within the previous year. Of the women 28%, and of the men 17%, respectively, had received professional consultations for oral symptoms. Conclusion: The current results on psychiatrically hospitalized patients emphasize the need for awareness of oral discomfort and its subsequent effects on the quality of life in this challenging patient group. Focus should also be placed on a wide range of support encouraging the patients to maintain good daily oral hygiene and seek professional dental help when needed.
引用
收藏
页数:7
相关论文
共 42 条
[11]   Further evidence that behavioral tests and neuropeptide mRNA and tissue level alterations can differentiate between typical and atypical antipsychotic drugs [J].
Bauer, R ;
Mayr, A ;
Lederer, W ;
Needham, PL ;
Kilpatrick, IC ;
Fleischhacker, WW ;
Marksteiner, J .
NEUROPSYCHOPHARMACOLOGY, 2000, 23 (01) :46-55
[12]   Further Evidence that Behavioral Tests and Neuropeptide mRNA and Tissue Level Alterations Can Differentiate between Typical and Atypical Antipsychotic Drugs [J].
Richard Bauer ;
Adelcy Mayr ;
Wolfgang Lederer ;
Patricia L Needham ;
Ian C Kilpatrick ;
Wolfgang W Fleischhacker ;
Josef Marksteiner .
Neuropsychopharmacology, 2000, 23 :46-55
[13]   Neurotensin receptor antagonist SR 142948A alters Fos expression and extrapyramidal side effect profile of typical and atypical antipsychotic drugs [J].
Binder, EB ;
Kinkead, B ;
Owens, MJ ;
Nemeroff, CB .
NEUROPSYCHOPHARMACOLOGY, 2004, 29 (12) :2200-2207
[14]   D-4 DOPAMINE-RECEPTOR BINDING-AFFINITY DOES NOT DISTINGUISH BETWEEN TYPICAL AND ATYPICAL ANTIPSYCHOTIC-DRUGS [J].
ROTH, BL ;
TANDRA, S ;
BURGESS, LH ;
SIBLEY, DR ;
MELTZER, HY .
PSYCHOPHARMACOLOGY, 1995, 120 (03) :365-368
[15]   Neurotensin Receptor Antagonist SR 142948A Alters Fos Expression and Extrapyramidal Side Effect Profile of Typical and Atypical Antipsychotic Drugs [J].
Elisabeth B Binder ;
Becky Kinkead ;
Michael J Owens ;
Charles B Nemeroff .
Neuropsychopharmacology, 2004, 29 :2200-2207
[16]   Discriminative stimulus properties of the atypical antipsychotic drug clozapine in rats trained to discriminate 1.25mg/kg clozapine vs. 5.0mg/kg clozapine vs. vehicle [J].
Prus, AJ ;
Philibin, SD ;
Pehrson, AL ;
Porter, JH .
BEHAVIOURAL PHARMACOLOGY, 2006, 17 (02) :185-194
[17]   Extended treatment with typical and atypical antipsychotic drugs -: Differential effects on the densities of dopamine D2-like and GABAA receptors in rat striatum [J].
Dean, B ;
Hussain, T ;
Scarr, E ;
Pavey, G ;
Copolov, DL .
LIFE SCIENCES, 2001, 69 (11) :1257-1268
[18]   Effects of amperozide and tiospirone, atypical antipsychotic 5-HT2 drugs, on food-reinforced behavior in rats [J].
Arolfo, MP ;
McMillen, BA .
PHYSIOLOGY & BEHAVIOR, 1999, 68 (1-2) :93-98
[19]   Health Care Costs in Patients with Fibromyalgia on Pregabalin vs. Duloxetine [J].
Burke, James P. ;
Sanchez, Robert J. ;
Joshi, Ashish V. ;
Cappelleri, Joseph C. ;
Kulakodlu, Mahesh ;
Halpern, Rachel .
PAIN PRACTICE, 2012, 12 (01) :14-22
[20]   Impact of antipsychotic polypharmacy on nonadherence of oral antipsychotic drugs - A study based on blood sample analyses from 24,239 patients [J].
Smith, Robert L. ;
Tveito, Marit ;
Kylleso, Lennart ;
Jukic, Marin M. ;
Ingelman-Sundberg, Magnus ;
Andreassen, Ole A. ;
Molden, Espen .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 37 :64-69